KR102282972B1 - 베타­카세인 ａ2 및 창자의 염증 예방 - Google Patents

베타­카세인 ａ2 및 창자의 염증 예방 Download PDF

Info

Publication number
KR102282972B1
KR102282972B1 KR1020157036746A KR20157036746A KR102282972B1 KR 102282972 B1 KR102282972 B1 KR 102282972B1 KR 1020157036746 A KR1020157036746 A KR 1020157036746A KR 20157036746 A KR20157036746 A KR 20157036746A KR 102282972 B1 KR102282972 B1 KR 102282972B1
Authority
KR
South Korea
Prior art keywords
casein
beta
milk
composition
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157036746A
Other languages
English (en)
Korean (ko)
Other versions
KR20160024884A (ko
Inventor
앤드류 존 클라크
말라브 수친 트리베디
Original Assignee
디 에이2 밀크 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102282972(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 디 에이2 밀크 컴퍼니 리미티드 filed Critical 디 에이2 밀크 컴퍼니 리미티드
Priority to KR1020217023199A priority Critical patent/KR102402455B1/ko
Publication of KR20160024884A publication Critical patent/KR20160024884A/ko
Application granted granted Critical
Publication of KR102282972B1 publication Critical patent/KR102282972B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020157036746A 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방 Active KR102282972B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217023199A KR102402455B1 (ko) 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
US61/829,764 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217023199A Division KR102402455B1 (ko) 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방

Publications (2)

Publication Number Publication Date
KR20160024884A KR20160024884A (ko) 2016-03-07
KR102282972B1 true KR102282972B1 (ko) 2021-07-28

Family

ID=51989162

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020157036746A Active KR102282972B1 (ko) 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방
KR1020217023199A Active KR102402455B1 (ko) 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020217023199A Active KR102402455B1 (ko) 2013-05-31 2014-05-30 베타­카세인 ａ2 및 창자의 염증 예방

Country Status (19)

Country Link
US (2) US20160113997A1 (enExample)
EP (2) EP3003485B1 (enExample)
JP (2) JP6867158B2 (enExample)
KR (2) KR102282972B1 (enExample)
CN (2) CN112316116A (enExample)
AU (2) AU2014271423B2 (enExample)
BR (1) BR112015029987A8 (enExample)
CA (1) CA2913890C (enExample)
CL (1) CL2015003507A1 (enExample)
DK (1) DK3003485T3 (enExample)
ES (1) ES2742306T3 (enExample)
IL (2) IL242833B (enExample)
MX (2) MX367794B (enExample)
MY (1) MY179497A (enExample)
PH (2) PH12015502674B1 (enExample)
RU (1) RU2669553C2 (enExample)
SG (2) SG10201709509RA (enExample)
WO (1) WO2014193248A1 (enExample)
ZA (1) ZA201508983B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015029987A8 (pt) * 2013-05-31 2021-12-07 A2 Milk Co Ltd Beta-caseína a2 e a prevenção de inflamação do intestino
KR102291660B1 (ko) * 2013-07-12 2021-08-19 디 에이2 밀크 컴퍼니 리미티드 락토스 불내증의 증상을 감소시키거나 예방하는 베타-카세인 a2
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient
MX392728B (es) * 2015-05-22 2025-03-24 A2 Milk Co Ltd Beta-caseina a2 y su capacidad antioxidante.
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
CA3017727C (en) 2016-03-30 2024-03-12 The A2 Milk Company Limited Beta-caseins and cognitive function
AU2016424981C1 (en) * 2016-09-30 2024-10-10 The A2 Milk Company Limited Beta-caseins and gut microbiota
EP3526201B1 (en) * 2016-10-14 2020-11-18 H. Hoffnabb-La Roche Ag Imidazole compounds as eaat3 inhibitors
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530B (zh) * 2022-11-15 2024-08-09 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法
CN117322467A (zh) * 2023-10-11 2024-01-02 东北农业大学 A2β-酪蛋白在制备功能性食品中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101065099B1 (ko) * 2002-10-04 2011-09-16 에이2 코포레이션 리미티드 β-카세인 Ａ2의 치료적 용도 및 β-카세인 Ａ2를 함유하는 식이 보충물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
CA2217820C (en) 1995-05-16 2011-03-01 Corran Norman Stuart Mclachlan Milk and milk products for preventing or treating heart disease
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
AU771754B2 (en) * 1999-06-29 2004-04-01 New Zealand Milk Institute Limited, The Prophylactic dietary supplement based on milk
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
WO2002019832A1 (en) 2000-09-08 2002-03-14 New Zealand Dairy Board MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
WO2002083164A2 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
WO2008041219A1 (en) * 2006-10-06 2008-04-10 Kerry Group Services International Limited A milk protein composition and use thereof
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
BR112015029987A8 (pt) * 2013-05-31 2021-12-07 A2 Milk Co Ltd Beta-caseína a2 e a prevenção de inflamação do intestino
KR102291660B1 (ko) * 2013-07-12 2021-08-19 디 에이2 밀크 컴퍼니 리미티드 락토스 불내증의 증상을 감소시키거나 예방하는 베타-카세인 a2

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101065099B1 (ko) * 2002-10-04 2011-09-16 에이2 코포레이션 리미티드 β-카세인 Ａ2의 치료적 용도 및 β-카세인 Ａ2를 함유하는 식이 보충물

Also Published As

Publication number Publication date
BR112015029987A2 (pt) 2017-07-25
CL2015003507A1 (es) 2016-12-16
AU2014271423B2 (en) 2018-12-20
RU2018131733A (ru) 2018-11-08
AU2018274937B2 (en) 2020-10-29
MX2015016493A (es) 2016-08-18
US20160113997A1 (en) 2016-04-28
CN105407971B (zh) 2020-11-17
EP3003485B1 (en) 2019-05-15
MY179497A (en) 2020-11-09
ES2742306T3 (es) 2020-02-13
CA2913890C (en) 2024-09-10
MX367794B (es) 2019-09-06
RU2018131733A3 (enExample) 2021-10-29
KR20160024884A (ko) 2016-03-07
NZ714912A (en) 2021-06-25
WO2014193248A1 (en) 2014-12-04
SG11201509769QA (en) 2015-12-30
MX2019010594A (es) 2019-10-15
PH12015502674A1 (en) 2016-03-07
IL242833B (en) 2019-07-31
JP2019165746A (ja) 2019-10-03
IL262302B (en) 2021-02-28
PH12019550096A1 (en) 2020-02-10
EP3542813A1 (en) 2019-09-25
KR102402455B1 (ko) 2022-05-25
MX391963B (es) 2025-03-21
CA2913890A1 (en) 2014-12-04
RU2669553C2 (ru) 2018-10-12
SG10201709509RA (en) 2017-12-28
CN105407971A (zh) 2016-03-16
JP6867158B2 (ja) 2021-04-28
EP3003485A1 (en) 2016-04-13
IL262302A (en) 2018-11-29
RU2015153113A (ru) 2017-07-05
JP7224242B2 (ja) 2023-02-17
HK1222362A1 (en) 2017-06-30
US20200179485A1 (en) 2020-06-11
BR112015029987A8 (pt) 2021-12-07
PH12015502674B1 (en) 2020-02-21
ZA201508983B (en) 2017-11-29
KR20210094674A (ko) 2021-07-29
AU2014271423A1 (en) 2015-12-24
US11911439B2 (en) 2024-02-27
CN112316116A (zh) 2021-02-05
AU2018274937A1 (en) 2019-01-03
DK3003485T3 (da) 2019-08-19
EP3003485A4 (en) 2016-11-30
JP2016520611A (ja) 2016-07-14

Similar Documents

Publication Publication Date Title
KR102282972B1 (ko) 베타­카세인 ａ2 및 창자의 염증 예방
JP6990154B2 (ja) ベータカゼインａ２およびラクトース不耐性の症状の低減または予防
RU2784851C2 (ru) Бета-казеин а2 и предотвращение воспаления кишечника
HK40013851A (en) Beta-casein a2 and prevention of inflammation of the bowel
HK1222362B (en) Composition comprising beta-casein a2 for use in the prevention of inflammation of the bowel
NZ753622A (en) Beta-casein a2 and prevention of inflammation of the bowel
NZ753622B2 (en) Beta-casein a2 and prevention of inflammation of the bowel
RU2791693C2 (ru) Бета-казеин а2 и уменьшение или предотвращение симптомов непереносимости лактозы
NZ714912B2 (en) Beta-casein a2 and prevention of inflammation of the bowel

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5